Home › Large Granular Lymphocytic Leukemia › Massachusetts
Large Granular Lymphocytic Leukemia clinical trials in Massachusetts
4 studies for Large Granular Lymphocytic Leukemia are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05592015A Study of Ruxolitinib and Duvelisib in People With Lymphoma
- Dana Farber Cancer Institute, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05010005A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05475925A Registry for People With T-cell Lymphoma
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.